Search This Blog

Tuesday, February 26, 2019

Jazz Pharmaceuticals up 10% to $140 after Q4 results, FY guidance top estimates

https://thefly.com/landingPageNews.php?id=2870769

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.